MERI PITANIELLO: Open Payments
NPI 1457901027 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,451 in 67 payments from 19 companies in 2025. Trend: 2023 $1,472 · 2024 $2,387 · 2025 $1,451
Food & beverage: $1,451
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $261 |
| GlaxoSmithKline, LLC. | 8 | $148 |
| AstraZeneca Pharmaceuticals LP | 5 | $136 |
| Exact Sciences Corporation | 7 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| Astellas Pharma US Inc | 4 | $86 |
| Abbott Laboratories | 4 | $77 |
| Eisai Inc. | 3 | $75 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Novo Nordisk Inc | 4 | $72 |
Products named: EVENITY, Cologuard Collection Kit, AIRSUPRA, Veozah, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Leqembi, GEMTESA.
Industry payments across TX — which companies pay providers there.
